Trailing Dividend / Share
$2.44
GSK plc (GSK) Dividend History
Income profile from 1984 to 2026 with payout safety and yield-on-cost trend
Dividend Yield
6.4%
Payout Ratio
43.9%
Sustainable
Dividend Streak
2 years
GSK Dividend Income Check
Safety
43.9% payout ratio with sustainable safety profile.
Consistency
2 straight years of dividend increases.
Income Trend
Yield on cost is 4.5% and trend is falling.
GSK Dividend Scorecard
Yield & Income
Dividend Yield6.4%
Trailing DPS$2.44
FrequencySemi-Annual
Payments / 12M4
Payout Safety
Earnings Payout43.9%
Earnings SafetySustainable
FCF Payout66.5%
FCF SafetyAdequate
Piotroski F-Score8/9
Growth
Growth Streak2 years
3Y CAGR0.3%
5Y CAGR-3.8%
Yield on Cost (5Y)4.5%
YOC Trendfalling
Total Returns
Buyback Yield0.0%
Total Shareholder Yield6.4%
1Y Total Return35.8%
5Y Total Return48.1%
Div Contribution (5Y)20.9%
Estimated $10K growth (return + dividends):
5Y ago$14,80710Y ago$16,76620Y ago$17,111
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). Different time windows can produce different outcomes depending on market regime and entry point.
GSK Income Growth Story
Dividend per share and yield on cost over time (43 years of payments)
GSK Dividend Safety Story
EPS is the container — dividend is what's drawn out
Get GSK's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
GSK plc distributes 43.9% of earnings as dividends (Sustainable). When measured against free cash flow—a stricter test—the payout ratio stands at 66.5%, rated "Adequate".
Piotroski F-Score: 8/9 — strong financial health.
Growth Track Record
GSK has raised its dividend for 2 consecutive years, with a 3-year CAGR of 0.3% and 5-year CAGR of -3.8%.
Total Shareholder Returns
Beyond cash dividends, GSK returns capital through share repurchases. The combined picture: 6.4% dividend yield, 6.4% total shareholder yield.
Income Trend & Total Return
Yield on cost (5-year basis) has reached 4.5% and is currently falling. The 5-year total return is 48.1%, with dividends contributing 20.9% of that performance.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $16,766 today.
GSK Recent Dividend Payments
Last 20 payments · Semi-Annual
TTM Total$8.32
Avg/Payment$0.4161
Latest Change-3.5%
| Ex-Date | Amount | Change | Yield % | Payment Date |
|---|---|---|---|---|
| May 15, 2026Latest | $0.4611 | ↓ -3.5% | 3.63% | Jul 9, 2026 |
| Feb 20, 2026 | $0.4776 | ↑ +10.3% | 2.98% | Apr 9, 2026 |
| Nov 14, 2025 | $0.4331 | ↑ +0.7% | 3.60% | Jan 8, 2026 |
| Aug 15, 2025 | $0.4300 | ↓ -1.1% | 4.20% | Oct 9, 2025 |
| May 16, 2025 | $0.4348 | ↑ +8.5% | 4.28% | Jul 10, 2025 |
| Feb 21, 2025 | $0.4007 | ↑ +3.0% | 4.23% | Apr 10, 2025 |
| Nov 15, 2024 | $0.3891 | ↑ +0.9% | 4.67% | Jan 9, 2025 |
| Aug 16, 2024 | $0.3857 | ↑ +2.5% | 3.65% | Oct 10, 2024 |
GSK Dividend vs Peers
Comparable companies in the same industry
#2 yield in peer group
Div Yield
6.4%
#2 of 9
Safety
Sustainable
43.9% payout
Streak
2Y
-3.8% 5Y CAGR
Total Shareholder
6.4%
#3 of 9
| Company | Mkt Cap | Yield | Payout | Streak | Safety |
|---|---|---|---|---|---|
2nd GSKGSK plc | $101.9B | 6.4% | 43.9% | 2 | Sustainable |
 AZNAstraZeneca PLC | $271.2B | 1.9% | 49.6% | 2 | Sustainable |
 NVSNovartis AG | $280.6B | 2.7% | 55.9% | 1 | Sustainable |
3rd  SNYSanofi | $102.4B | 5.1% | 58.7% | 3 | Sustainable |
1st  PFEPfizer Inc. | $143.5B | 6.8% | 1.3% | 15 | Sustainable |
 MRKMerck & Co., Inc. | $281.2B | 2.9% | 44.8% | 15 | Sustainable |
 BMYBristol-Myers Squibb… | $110.3B | 4.6% | 71.5% | 4 | Watch |
 LLYEli Lilly and Compan… | $1.0T | 0.5% | 26.1% | 11 | Sustainable |
 ABBVAbbVie Inc. | $383.2B | 3.0% | 2.8% | 43 | Sustainable |
GSK Annual Dividend History (1984–2026)
43 years of dividend data
GrowthDecline
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2026YTD | $0.94 | — | 2 | — | — | — | 2.5% |
| 2025 | $1.70 | 9.1% | 4 | $5.56 | 30.5% | 3.27x | 4.5% |
| 2024 | $1.56 | 12.0% | 4 | $1.24 | 125.6% | 0.80x | 4.1% |
| 2023 | $1.39 | -17.3% | 4 | $2.40 | 57.9% | 1.73x | 3.7% |
| 2022 | $1.68 | -27.5% | 4 | $2.40 | 70.0% | 1.43x | 4.5% |
| 2021 | $2.32 | 12.7% | 4 | $2.70 | 85.9% | 1.16x | 6.1% |
| 2020 | $2.06 | -0.1% | 4 | $2.86 | 72.0% | 1.39x | 5.5% |
| 2019 | $2.06 | -4.6% | 4 | $2.32 | 88.8% | 1.13x | 5.5% |
| 2018 | $2.16 | 4.7% | 4 | $1.82 | 118.7% | 0.84x | 5.7% |
| 2017 | $2.06 | -25.5% | 4 | $0.78 | 264.6% | 0.38x | 5.5% |
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into GSK consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
42+ years return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
GSK — Frequently Asked Questions
Quick answers to the most common questions about buying GSK stock.
How much dividend does GSK pay per share?
GSK plc (GSK) pays a trailing 12-month dividend of $2.44 per share, with a current dividend yield of +6.4%. Payments are made Semi-Annual.
When is GSK's next ex-dividend date?
GSK's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. GSK typically pays dividends Semi-Annual.
Is GSK's dividend safe?
GSK's dividend safety is rated "Sustainable" based on an earnings payout ratio of +43.9% and FCF payout ratio of +66.5%. The 2-year growth streak provides moderate confidence.
How many years has GSK increased its dividend?
GSK has 2 consecutive years of dividend growth. The 5-year dividend CAGR is -3.8%.
How often does GSK pay dividends?
GSK plc pays dividends Semi-Annual. The trailing 12-month total is $2.44 per share. Dividend data on this page covers 42+ years from 1984 to 2026.
How much would $10,000 invested in GSK grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in GSK five years ago would be worth approximately $14,807 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is GSK's yield on cost for long-term holders?
GSK's yield on cost — the current dividend divided by the original purchase price — is +4.5% for a 5-year holding period. This means long-term holders earn a higher effective yield than today's +6.4% market yield, thanks to the lower original cost basis.